A double-blind randomized controlled trial revealed that atomoxetine, a selective norepinephrine reuptake inhibitor, effectively enhanced cognitive functions, such as memory, inhibitory control, and attention, in METH users (Rabiey et al., 2022)
In July 2022, the FDAs Pharmacy Compounding Advisory Committee (PCAC) voted against inclusion of enclomiphene citrate on the final 503A bulks list, though the material remains listed as category 1 on the most recent iteration of the 503A bulk drugs list
For the fastest results, make sure you are consistently taking your medication
Beware of other sites who sell imported B12 from Asia Before using this medicine, a health care professional will provide detailed instructions for appropriate use of this medicine